Glina Sidney, Damião Ronaldo, Abdo Carmita, Afif-Abdo João, Tseng Li-Jung, Stecher Vera
Instituto H. Ellis, São Paulo, Brazil.
J Sex Med. 2009 Jan;6(1):268-75. doi: 10.1111/j.1743-6109.2008.01026.x.
Psychosocial manifestations of erectile dysfunction (ED) differ across cultures. Understanding the treatment response to ED medications within cultural groups can aid in resource allocation and in developing treatment strategies.
Evaluate the effect of sildenafil treatment on self-esteem, confidence, and sexual relationship satisfaction in Brazilian men with ED.
The Self-Esteem and Relationship (SEAR) questionnaire, a validated, 14-question instrument developed to specifically address self-esteem and relationship issues within the context of ED.
Men aged 18 years or older with a clinical diagnosis of ED (< or = 21 on the Sexual Health Inventory for Men) and in a stable relationship with a partner during the study were eligible. The primary end point was a change from baseline in the self-esteem subscale of the SEAR questionnaire. Thirteen Brazilian sites participated in a randomized, double-blind, placebo-controlled trial of sildenafil treatment for ED. Patients were randomized to receive either 50 mg of sildenafil (adjustable to 25 mg or 100 mg based on patient response) or matching placebo approximately 1 hour before anticipated sexual activity but not more than once a day.
At the end of double-blind treatment, 63 and 66 patients in the placebo and sildenafil groups, respectively, from 13 Brazilian sites were assessed for efficacy. Brazilian patients receiving sildenafil had significantly greater improvements in their scores on the SEAR self-esteem subscale (42.9 [95% confidence interval 35.7-50.0]) compared with placebo (21.1 [95% confidence interval 13.7-28.6]; P < 0.0001). Effect sizes ranged from 0.91 to 1.25 for individual SEAR components.
The psychosocial parameters in Brazilian men with ED assessed by the SEAR questionnaire showed significant improvements in self-esteem, confidence, and relationships after treatment with sildenafil.
勃起功能障碍(ED)的社会心理表现因文化而异。了解不同文化群体对ED药物的治疗反应有助于资源分配和制定治疗策略。
评估西地那非治疗对患有ED的巴西男性自尊、自信和性关系满意度的影响。
自尊与关系(SEAR)问卷,这是一种经过验证的、有14个问题的工具,专门用于解决ED背景下的自尊和关系问题。
年龄在18岁及以上、临床诊断为ED(男性性健康量表得分≤21)且在研究期间与伴侣关系稳定的男性符合条件。主要终点是SEAR问卷自尊子量表相对于基线的变化。13个巴西研究地点参与了一项西地那非治疗ED的随机、双盲、安慰剂对照试验。患者被随机分配在预期性活动前约1小时服用50毫克西地那非(可根据患者反应调整为25毫克或100毫克)或匹配的安慰剂,但每天不超过一次。
在双盲治疗结束时,对来自13个巴西研究地点的安慰剂组和西地那非组的63例和66例患者进行了疗效评估。与安慰剂组(21.1 [95%置信区间13.7 - 28.6];P < 0.0001)相比,接受西地那非治疗的巴西患者在SEAR自尊子量表上的得分有显著更大的改善(42.9 [95%置信区间35.7 - 50.0])。SEAR各个组成部分的效应大小在0.91至1.25之间。
通过SEAR问卷评估,患有ED的巴西男性的社会心理参数显示,西地那非治疗后自尊